Interventional cardiology in a whole new light

Open menu

News & Events

Opsens reports 2014 results

25 November 2014

Quebec City, Quebec, November 25, 2014 – Opsens Inc. (“Opsens”) (TSXV:OPS) today released results for the year ended August 31, 2014. Latest Highlights for Opsens Receipt of CE marking allowing Opsens to sell the OptoWire and OptoMonitor in Europe. The OptoWire and OptoMonitor are Opsens’ products developed for the measurement of Fractional Flow Reserve (“FFR”)…

Read more

Opsens Gets CE Marking

19 November 2014

Quebec City, Quebec, November 19, 2014 – Opsens Inc. (TSXV:OPS) (“Opsens” or the “Company”) is pleased to announce that it has been granted CE marking for OptoWire and OptoMonitor, which allows these Fractional Flow Reserve (FFR) products for patients with coronary artery disease to be marketed in Europe, the world’s second largest market. “Following the…

Read more

Opsens to present at SeeThruEquity fall Microcap Investor Conference

11 November 2014

Quebec City, Quebec, November 11, 2014 – Opsens Inc. (“Opsens”) (TSX-V: OPS) developer of products for the measurement of Fractional Flow Reserve (“FFR”) in patients suffering from coronary artery disease is pleased to announce that Louis Laflamme, President and CEO will present at SeeThruEquity’s Microcap Investor Conference on Wednesday November 12, 2014. The one-day event…

Read more